Yuhua Zhang
The convergence of biotechnology and pharmaceutical sciences has ushered in a new era of drug development, revolutionizing the way we approach the discovery, design, and delivery of medications. Biotechnology, with its profound understanding of living organisms and their molecular processes, has become a driving force behind the development of innovative therapeutics. This paper explores the impact of biotechnology on drug development, focusing on the integration of cutting-edge science and technology to address complex medical challenges. From recombinant DNA technology and monoclonal antibodies to gene therapies and personalized medicine, biotechnology-driven drug development has opened doors to targeted, precise, and patient-centric treatments. This paper delves into the advancements in biotechnology, the challenges faced in this domain, and the potential future directions that hold promise for transforming healthcare through novel drug therapies.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 